With this series we will bring you the latest FDA-related news. This week we cover Biden's delay in picking for FDA Commissioner.
For more news in diabetes advocacy and policy, check out our compiled news updates here.
President Biden has yet to announce his nomination for FDA Chief and there has been no public explanation for this delay. According to STAT, this role is difficult to fill because you need to find someone who is qualified and willing to take on the politicized role. The Biden administration said that “the choice of FDA Commissioner is critically important” but has not explained the nomination delay.
Why it matters: Whoever Biden nominates will garner criticism from policymakers because “Politicians want scientific and industry expertise, but they also want a nominee who doesn’t have any financial ties to the industry he or she is about to regulate.” The FDA Commissioner oversees the process of diabetes therapy and technology approval which impacts all people with diabetes.